Mirum Pharmaceuticals, Inc.
Develops and commercializes therapies for rare, debilitating liver conditions.
MIRM | US
Overview
Corporate Details
- ISIN(s):
- US6047491013
- LEI:
- Country:
- United States of America
- Address:
- 989 EAST HILLSDALE BOULEVARD, SUITE 300, 94404 FOSTER CITY
- Website:
- https://mirumpharma.com/
- Sector:
- Manufacturing
Description
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing and commercializing therapies for rare diseases, with a primary focus on debilitating liver conditions affecting both children and adults. The company's lead commercial product is LIVMARLI® (maralixibat), an oral solution for the treatment of cholestatic pruritus in patients with Alagille syndrome. Mirum's clinical pipeline is advancing other potential treatments, including volixibat, for various rare cholestatic liver diseases. The company's mission is to transform the treatment landscape for patients with significant unmet medical needs by advancing its scientific programs from discovery through commercialization.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Mirum Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Mirum Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Mirum Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
